Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
Randomized controlled trial · Schizophr Res · 2018. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
Koola MM, Sklar J, Davis W et al.
Schizophr Res · 2018
- PubMed ID
- 28705532
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.